Medindia
Medindia LOGIN REGISTER
Advertisement

Vion Pharmaceuticals Announces FDA Conclusion

Wednesday, December 30, 2009 Corporate News
Advertisement
HOVON Trial As Designed Does Not Gain SPA Agreement

Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close